Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
study id #: NCT04174157
condition: Spinal Muscular Atrophy (SMA)
status: Recruiting
purpose:Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN protein levels and a selective dysfunction of motor neurons. SMA is an autosomal recessive, early childhood disease with an incidence of 1:10,000 live births. SMA is the leading cause of infant mortality due to genetic diseases.
Until recently, the mainstay of treatment for these patients was supportive medical care. However, advances in medical treatment focusing on gene replacement, gene enhancement, motor neuron protection and muscle enhancement is likely to change the management and prognosis of these patients in the future.
The purpose of this registry is to assess the long term outcomes of patients with SMA in the context of advances in treatment options.
intervention: Prospective observational registry, Zolgensma
results: https://clinicaltrials.gov/ct2/show/results/NCT04174157
last updated: January 13, 2022
-
Integrating Newborn Screening for Spinal Muscular Atrophy Into Health Care Systems: An Australian Pilot ProgrammeAim: This study dynamically designed, ev...
-
Basil Darras, MDDr. Basil Darras serves as an expert in ...
-
DNA From Saliva Has Potential for Detecting SMAA noninvasive method using dried saliva ...
-
SMA Type 2 – Looking After Your Child Who Has Had a Recent DiagnosisOne of the first questions many families...
-
Spine Surgery Effective in SMA Type 1 Children, But Not Without RisksSurgery to correct kyphoscoliosis — a ...
-
Boston Children’s Hospital – Spinal Muscular Atrophy ProgramThe Spinal Muscular Atrophy Program at B...
-
Biogen Exercises Option With Ionis to Develop and Commercialize Investigational ASO for SMABiogen, Inc. and Ionis Pharmaceuticals, ...